DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.
Allelic losses on 19q are found in the majority of oligodendroglial tumors and approximately one-third of diffuse astrocytomas. However, the tumor suppressor genes (TSG) on 19q are still elusive. Using cDNA microarray expression profiling, EMP3 at 19q13.3 was among those genes showing the most pronounced expression differences. In line with this, other authors reported EMP3 as being epigenetically silenced in neuroblastomas and astrocytomas. To further investigate EMP3 as a TSG candidate on 19q13.3, we performed molecular analysis of this gene in 162 human gliomas. Mutation analysis did not reveal EMP3 alteration in 132 gliomas. In oligodendroglial tumors, we found that aberrant methylation in the 5'-region of EMP3 was significantly associated with reduced mRNA expression and LOH 19q. In astrocytomas, EMP3 hypermethylation was also paralleled by reduced expression but was independent of the 19q status. EMP3 hypermethylation was detected in more than 80% of diffuse, anaplastic astrocytomas and secondary glioblastomas. Primary glioblastomas, however, mostly lacked EMP3 hypermethylation and frequently overexpressed EMP3. Our data corroborate that oligodendroglial and astrocytic gliomas often show EMP3 hypermethylation and aberrant expression. Furthermore, our findings suggest that primary and secondary glioblastomas are not only characterized by distinct genetic profiles but also differ in their epigenetic aberrations.
Kunitz
Annegret
A
Department of Neuropathology, Charité, Universitätsmedizin Berlin, D-13353 Berlin, Germany.
Wolter
Marietta
M
van den Boom
Jörg
J
Felsberg
Jörg
J
Tews
Björn
B
Hahn
Meinhard
M
Benner
Axel
A
Sabel
Michael
M
Lichter
Peter
P
Reifenberger
Guido
G
von Deimling
Andreas
A
Hartmann
Christian
C
D000328:Adult; D001254:Astrocytoma / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D001932:Brain Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics*; D019175:DNA Methylation; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D020868:Gene Silencing / Q000502:physiology; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005910:Glioma / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000235:genetics*; D009837:Oligodendroglioma / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D020411:Oligonucleotide Array Sequence Analysis
C485157:EMP3 protein, human; D008562:Membrane Glycoproteins